Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;20(1):61-67.
doi: 10.3892/etm.2020.8572. Epub 2020 Feb 27.

Dynamics of digital ulcers in systemic sclerosis

Affiliations

Dynamics of digital ulcers in systemic sclerosis

Carmen Bobeică et al. Exp Ther Med. 2020 Jul.

Erratum in

Abstract

Systemic sclerosis (SSc) is a collagenosis with insufficiently known etiopathogenesis, characterized by microvasculopathy and excessive fibrosis in the context of an autoimmune disorder. The incompletely elucidated pathogenesis and limited therapeutic options, disabling aspects, skin lesions and pain determine important functional and psychological deficiencies which affect the quality of life. It is imperative to observe and correlate individual clinical and paraclinical data to optimize disease management. A group of 22 patients diagnosed with SSc, hospitalized in a university clinic in Bucharest was included in an observational study. The evolution of digital ulcers was evaluated as an indicator of vasculopathy and their status and dynamics were correlated with clinical elements reflecting the fibrotic aspect of the disease. The present study shows that the Raynaud phenomenon is almost always present during the course of the disease, but its presence is not always associated with digital ulcers. The existing data in the literature show that fibrosis is subsequent to vasculopathy, but this study did not reveal causality between these two aspects of pathogenesis. The presence of microstomia and digital contracture was identified in the presence of digital ulcers, but also in their absence. The etiopathogenic mechanisms with multiple unknown involved factors open the opportunity to investigate many aspects of SSc for optimal aiming of therapeutic interventions.

Keywords: Raynaud's phenomen; digital ulcers; microangiopaty; microstomia; microvasculopathy; systemic sclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Status of digital ulcers - frequency distribution.
Figure 2
Figure 2
Dynamics of digital ulcers - frequency distribution.
Figure 3
Figure 3
Evolution of digital ulcers - frequency distribution.
Figure 4
Figure 4
Pattern of blood capillary damage - frequency distributions.
Figure 5
Figure 5
Correlation of acroosteolysis with digital ulcers - frequency distributions.
Figure 6
Figure 6
Correlation of microstomia with digital ulcers - frequency distributions.
Figure 7
Figure 7
Correlation between the high degree microstomia and digital ulcers - frequency distribution.
Figure 8
Figure 8
Correlation between digital ulcers and absence of digital contracture - frequency distribution.
Figure 9
Figure 9
Correlation of digital ulcers with presence of digital contracture - frequency distribution.
Figure 10
Figure 10
Correlation of digital ulcers with digital contracture - frequency distribution.

Similar articles

Cited by

  • Etiological factors of systemic sclerosis in the southeast region of Romania.
    Bobeica C, Niculet E, Craescu M, Halip AI, Popescu IA, Draganescu ML, Onisor C, Stefanescu B, Gheuca-Solovastru L. Bobeica C, et al. Exp Ther Med. 2021 Jan;21(1):79. doi: 10.3892/etm.2020.9511. Epub 2020 Nov 26. Exp Ther Med. 2021. PMID: 33363590 Free PMC article.
  • Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report.
    Bobeica C, Rebegea L, Murariu G, Dobre M, Nechita A, Tatu AL, Niculet E, Anghel L, Fotea S, Craescu M. Bobeica C, et al. Exp Ther Med. 2022 Jan;23(1):15. doi: 10.3892/etm.2021.10937. Epub 2021 Oct 29. Exp Ther Med. 2022. PMID: 34815767 Free PMC article.
  • Predictive value of immunological markers in systemic sclerosis.
    Bobeica C, Niculet E, Halip AI, Gheuca-Solovastru L, Draganescu ML, Popescu IA, Onisor C, Chirobocea S, Lungu M, Craescu M. Bobeica C, et al. Exp Ther Med. 2021 Sep;22(3):994. doi: 10.3892/etm.2021.10426. Epub 2021 Jul 14. Exp Ther Med. 2021. PMID: 34345276 Free PMC article.
  • Paraclinical Aspects in Systemic Sclerosis.
    Bobeica C, Niculet E, Musat CL, Craescu M, Stefanescu BI, Dinu C, Chiscop I, Chirobocea S, Nechita L, Iancu AV, Stefanescu V, Balan G, Stefanopol IA, Pelin AM, Tatu AL. Bobeica C, et al. Int J Gen Med. 2022 Apr 26;15:4391-4398. doi: 10.2147/IJGM.S355662. eCollection 2022. Int J Gen Med. 2022. PMID: 35502184 Free PMC article. Review.
  • Old and new therapeutic strategies in systemic sclerosis (Review).
    Bobeica C, Niculet E, Tatu AL, Craescu M, Vata D, Statescu L, Iancu AV, Musat CL, Draganescu ML, Onisor C, Lungu M, Fotea S, Nechita A, Stefanescu BI, Gheuca-Solovastru L. Bobeica C, et al. Exp Ther Med. 2022 Feb;23(2):134. doi: 10.3892/etm.2021.11057. Epub 2021 Dec 13. Exp Ther Med. 2022. PMID: 35069815 Free PMC article. Review.

References

    1. Chihara M, Kurita M, Yoshihara Y, Asahina A, Yanaba K. Clinical significance of serum galectin-9 and soluble CD155 levels in patients with systemic sclerosis. J Immunol Res. 2018;2018(9473243) doi: 10.1155/2018/9473243. - DOI - PMC - PubMed
    1. Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD) Respir Res. 2019;20(13) doi: 10.1186/s12931-019-0980-7. - DOI - PMC - PubMed
    1. Butt SA, Jeppesen JL, Fuchs C, Mogensen M, Engelhart M, Torp-Pedersen C, Gislason GH, Jacobsen S, Andersson C. Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: A nationwide cohort study. BMC Rheumatol. 2018;2(36) doi: 10.1186/s41927-018-0043-6. - DOI - PMC - PubMed
    1. Friedrich S, Lüders S, Glimm AM, Werner SG, Schmittat G, Burmester GR, Backhaus M, Riemekasten G, Ohrndorf S. Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis. Arthritis Res Ther. 2019;21(96) doi: 10.1186/s13075-019-1875-1. - DOI - PMC - PubMed
    1. McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, Grant C, Singh S, Awwal K, Koci K, et al. Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale) 2018;8(235) doi: 10.4172/2161-1149.1000235. - DOI - PMC - PubMed